The Trinity Biomedical Sciences Institute (TBSI) is an environment where innovative and interdisciplinary approaches are leading to scientific discoveries of biomedical importance, ultimately giving rise to better patient care.
News, Events and Discoveries
Many TBSI amongst the eleven TCD researchers who have been awarded €4 million to tackle global health challenges .
Scientists create luminescent gels with multitude of applications from counterfeiting to bio-sensing .
Centre for Biomedical Engineering at TBSI: Prof Michael Monaghan, Dr Matteo Solazzo and team have developed a low cost prototype wearable sensor for health care applications .
The immunologists, led by Dr Nigel Stevenson, Assistant Professor in Viral Immunology at TBSI, have discovered how SARS and MERS proteins block the induction of antiviral proteins, which prevents us from mounting a strong innate immune response against infection .
TBSI professor Richard Porter links with Artelo to investigate Fatty Acid Binding Protein inhibition in cancer.
Discovery of new immune process that regulates inflammation in human fat may help manage obesity. TCD Comms .
North-South Cancer Liquid Biopsies Research Programme. Irish Times.
Researchers discover new therapeutic target for severe asthma, lead investigator Luke O’Neill .
Tánaiste Leo Varadkar launches Irish-led €10 million project to deliver ‘precision medicine’ for Motor Neuron Disease .
Why do we forget? New theory proposes ‘forgetting’ is actually a form of learning .
Scientists discover how key protein drives our immune response against viruses .